LS301-IT

N/A

Report date: 2024/10/18 17:37:56
NME

Base Information

Drug NameLS301-IT
Drug Alias NameLS301-IT
ClassificationSmall molecules > Heterocyclic drugsDiagnostic agent (In vivo)
Mechanisms of ActionDiagnostic imaging enhancersAnnexin A2 binders
TargetsAnnexin A2
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungLung Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIntegro Theranostics
China Registration ClassN/A

Develop Information

Active CompaniesIntegro Theranostics
Inactive CompaniesWashington University
Active IndicationsCarcinoma, Non-Small-Cell LungLung NeoplasmsBreast Neoplasms +[5] 
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A